Patent ID: 11931375
Assignee: VOYAGER THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. The method of claim 5, wherein the modulatory polynucleotide comprises from 5′ to 3′:
(i) the 5′ flanking region, wherein the nucleotide sequence encoding the 5′ flanking region comprises SEQ ID NO: 3;
(ii) the sense strand sequence, wherein the nucleotide sequence encoding the sense strand sequence comprises SEQ ID NO: 7;
(iii) the loop region, wherein the nucleotide sequence encoding the loop region comprises SEQ ID NO: 4;
(iv) the antisense strand sequence, wherein the nucleotide sequence encoding the antisense strand sequence comprises SEQ ID NO: 8; and
(v) the 3′ flanking region, wherein the nucleotide sequence encoding the 3′ flanking region comprises SEQ ID NO: 5.